Bone affinity of a bisphosphonate-conjugated protein in vivo

Biotechnology Progress

Volumn 16, Issue 6, 2000, Pages 1115-1118

  Uludag, H ^a   Gao, T ^b   Wohl, G R ^b   Kantoci, D ^b   Zernicke, R F ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Faculty of Medicine   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINO 1,1 DIPHOSPHONATE METHANE; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN; BOVINE SERUM ALBUMIN; GROWTH FACTOR; IN VIVO STUDY; PROTEIN ENGINEERING; PROTEIN PRODUCTION; RAT; TIBIA;

ANIMALS; BONE AND BONES; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; FEMALE; OSTEOPOROSIS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN, BOVINE;

BOVINAE;

EID: 0034523718     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp000066y     Document Type: Review

References (9)

1. Prevalence and incidence of vertabral deformities
2. Therapy for osteoporosis: Miscellaneous and experimental agents
3. Growth factors as therapeutic agents
4. The histopathology of kidney changes in rats and monkeys following intravenous administration of massive doses of FCE 26184, human basic fibroblast growth factor
5. Infusion of plateletderived growth factor or bFGF induces selective glomerular mesengial cell proliferation and matrix accumulation in rats
6. Bisphosphonate conjugation to proteins as a means to impart bone affinity
7. The ovariectomized rat model of postmenopausal bone loss
8. Bisphosphonate action: Alendronate localization in rat bone and effects on osteoclast ultrastructure
9. Bone-seeking radiopharmaceuticals